Viewing nowCombinationJadion Duo Tablet 12.5/500 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Genupharma Co., Ltd.

MFDS item code 202302585 · Approved 2023.08.30 · Insurance code 698004720
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medicine is used to help adult patients with type 2 diabetes control their blood sugar in conjunction with diet and exercise therapy. It is particularly effective in patients whose blood sugar is not adequately controlled, and caution is required when administering it to patients with concomitant cardiovascular disease. This medicine helps to improve blood sugar levels and is used to assist diabetes management and enhance overall health.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medicine can cause a rare complication known as severe lactic acidosis; thus, patients should consult a doctor immediately if symptoms appear. Caution is also necessary when used with other diabetes medications as this may result in hypoglycemia. It should not be used in patients with moderate to severe renal impairment. It should also be avoided in cases of acute renal issues, severe infections, or heart problems. Pregnant or breastfeeding women should not take this medicine. Kidney function tests should be performed before starting this medication, and renal function should be regularly monitored during treatment. Use of this drug may be temporarily halted in situations posing a risk of fluid loss such as dehydration, vomiting, or diarrhea. It may increase the risk of urinary tract infections and genital infections, so any signs of infection should be reported immediately. Patients with impaired liver function must also use this medicine with caution. Patients scheduled for surgery should stop this medication 48 hours prior to surgery and can resume after renal function has returned to normal post-operation. Avoiding alcohol consumption during the period of taking this medication is recommended. Elderly patients or those with impaired renal function should take this medication with particular caution and may require dosage adjustments. Symptoms of hypoglycemia may appear while taking this medication, and immediate action should be taken if symptoms occur. Regular blood tests are recommended as blood levels of vitamin B12 may decrease. Regular testing should be conducted to check for adverse reactions, and if any abnormal symptoms occur, a doctor should be consulted immediately.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container away from air and moisture, and it is best kept at room temperature between 1 and 30 degrees Celsius. This storage condition helps maintain the effectiveness of the drug and prevents degradation.
Biconvex, oval film-coated tablet with a light brownish-purple color
60 tablets/bottle, 30 tablets/bottle, 60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Genupharma Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.